SCHEMBL537858

SCHEMBL537858

COc1ccc(CN2CCC3NNc4nc(SC)nc2c43)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGIR P43119 1/20 0.39
MAPT P10636 4/20 0.38
ALDH1A1 P00352 3/20 0.38
LMNA P02545 3/20 0.38
KDM4E B2RXH2 2/20 0.38
GAA P10253 1/20 0.37
SIGMAR1 Q99720 1/20 0.34
POLB P06746 1/20 0.34
PDE2A O00408 1/20 0.34
SMN1; SMN2 Q16637 3/20 0.33
MMP1 P03956 1/20 0.33
MMP13 P45452 1/20 0.33
KMT2A Q03164 1/20 0.33
ROCK2 O75116 2/20 0.33
CCR2 P41597 1/20 0.33
ROCK1 Q13464 1/20 0.33
HTT P42858 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C19 P33261 1/20 0.33
SPHK2 Q9NRA0 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL537884 0.87 ALDH1A1 (0.34) MAPTALDH1A1LMNAKDM4EGAA
SCHEMBL537664 0.83 PTGIR (0.39) PTGIRMAPTALDH1A1LMNAKDM4E
SCHEMBL2811869 0.81 MAPT (0.43) MAPTALDH1A1KDM4EGAASMN1; SMN2
SCHEMBL2814064 0.81 PDE5A (0.40) ROCK2CCR2ROCK1
SCHEMBL2813447 0.81 MAPT (0.41) MAPTALDH1A1LMNASIGMAR1POLB
SCHEMBL2812933 0.81 CLK4 (0.41) MAPTALDH1A1LMNAPOLBSMN1; SMN2
SCHEMBL537584 0.81 ACHE (0.45) MAPTSIGMAR1KMT2A
SCHEMBL538466 0.80 SIGMAR1 (0.41) PTGIRMAPTALDH1A1LMNAKDM4E
SCHEMBL2812231 0.80 EHMT2 (0.40) MAPTLMNAGAASIGMAR1SMN1; SMN2
SCHEMBL2814053 0.79 SIGMAR1 (0.48) ALDH1A1LMNAKDM4EGAASIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343983-B2 Substituted pyrazolo-pyrimidine compounds ARQULE, INC. (US) 2013-01-01 US disclosed
EP-2414359-A1 PERI-FUSED PYRAZOLO-PYRIMIDINE COMPOUNDS ArQule, Inc. (US) 2012-02-08 EP disclosed
WO-2010114905-A1 PERI-FUSED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-10-07 WO disclosed
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS DPYD, TYMP, TP53 PTGIR 602/4885MAPT 2947/4885ALDH1A1 924/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.